Patrick Cashman is president of USAntibiotics, the sole licensed American manufacturer of amoxicillin-based Augmentin and Amoxil solid, oral beta-lactam antibiotics and authorized generics. Based in Tennessee, he leads the team of R&D, quality, manufacturing, regulatory affairs, supply chain and commercial professionals who operate from the company’s world-class, 394,000 square foot production facility that can produce and fulfill 100 percent of the nation’s demand for these essential, life-saving medications.
With three decades in the industry, Patrick has served in executive management positions in multinational pharmaceutical organizations in the U.S., Canada and Mexico. With a focus on growth, quality and innovation, he is recognized for his knowledge and industry experience, commitment to operational excellence, delivery of exceptional client support and cultivation of high-performance teams. During his career – which includes senior leadership positions at Lundbeck, Pfizer and SmithKline Beecham – he established new subsidiaries in key markets, launched new pharmaceutical brands and led co-commercialization teams with partners around the world.
Patrick has received numerous awards, including international honors for profitability, sales growth, innovation and a new oncology business unit, while at Lundbeck Canada. His focus on patient centricity earned him the Eye for Pharma Lifetime Achievement Award. He also champions mental health awareness, having presented at the Champions of Mental Health Awards and to members of the Canadian Parliament. Patrick holds an MBA from Thunderbird School of International Business at Arizona State University and Bachelor of Science in Economics degree from the University of Wisconsin.
Vice President, Strategic Initiatives
Jeff Gramm serves as vice president of strategic initiatives at USAntibiotics, the sole licensed American manufacturer of amoxicillin-based Augmentin and Amoxil solid, oral beta-lactam antibiotics and authorized generics. In this position, he focuses on new opportunities to grow the business and accelerate antibiotics distribution from the company’s world-class, 394,000 square foot pharmaceutical manufacturing facility in Bristol, Tennessee, and achieve key milestones in building the nation’s supply of these life-saving medications.
With more than 40 years working in the life science industry, Jeff’s expertise and extensive pharmaceutical experience ranges from research and development, to engineering, to bulk chemical, solid dose processes, biotech/fermentation and sterile operations.
Over the course of his career and during his tenure with GlaxoSmithKline, he held a variety of progressive leadership roles. Jeff was senior site director for the international pharmaceutical division, responsible for production, warehouse, logistics, procurement, engineering, safety and quality, as well as finance, HR and IT operations. He also has served as an operational excellence expert, leading Lean Manufacturing and Six Sigma improvements that led to the Bristol site becoming one of the top three improvement sites in GlaxoSmithKline’s network of more than 100 sites worldwide.
Jeff earned a Bachelor of Science in Chemical Engineering degree from the University of Rhode Island and holds professional engineering certification as a member of the Professional Engineers of North Carolina. He also is a member of the International Institute of Pharmaceutical Engineers and the American Institute of Chemical Engineers.
Vice President, Operations
Ronald Maye serves as vice president of operations at USAntibiotics, the sole licensed American manufacturer of amoxicillin-based Augmentin and Amoxil solid, oral beta-lactam antibiotics and authorized generics. He brings more than 30 years of experience in FDA pharmaceutical manufacturing with administrative responsibilities for personnel management, financial management, organizational structure and the development of life-saving medications.
At USAntibiotics, Ronald leads operations, including manufacturing, packaging, engineering, logistics, procurement, information technology, safety, and health and environmental functions at the company’s world-class, 394,000 square foot pharmaceutical manufacturing facility in Bristol, Tennessee.
Throughout his career, Ronald has held an array of leadership roles, including site director and general manager for Neopharma and Dr. Reddy’s Laboratories. Prior to that, he worked for GlaxoSmithKline for 20 years, holding various management positions in production, logistics, engineering and operational excellence, as well as serving as a Lean Sigma educator and trainer. Before his career in the pharmaceutical industry, he held various leadership roles for Unisys Corporation.
Ronald earned a Bachelor of Science in Engineering Technology and a Master of Science in Industrial Arts and Technology Education degree from East Tennessee State University, where he also completed all doctoral hours and internships toward an Ed.D. in Private Sector Leadership and Policy Analysis. He has delivered Lean Sigma continuous improvement and change management training and workshops at organizations around the world, and serves as a Tennessee Supreme Court Rule 31 Listed Mediator trained for general civil and family cases.
Vice President, Quality & Regulatory Affairs
Linda Robbins is vice president of quality and regulatory affairs at USAntibiotics, the sole licensed American manufacturer of amoxicillin-based Augmentin and Amoxil solid, oral beta-lactam antibiotics and authorized generics. With more than 30 years of pharmaceutical experience, she oversees compliance with regulatory requirements for the development, manufacturing, packaging, testing, storage/distribution and post-marketing requirements for these life-saving medications. She also supports the company’s vision and strategic initiatives with her oversight of regulatory affairs.
Helping champion the company’s strong culture, compliance record and commitment to operational excellence, Linda has been a dedicated leader in securing the ongoing supply of these medications for the benefit of American patients. Over the course of her career, she has held a variety of progressive technical and leadership roles, ranging from chemist to QC laboratories manager to quality director during her tenure at the world-class, 394,000 square foot production facility in Bristol, Tennessee. Her technical experience includes prior work in the chemical industry as an R&D technician at a Hoechst Celanese Research Center. While at GlaxoSmithKline, Linda co-designed its multi-million dollar pharmaceutical laboratories, receiving accolades for functionality, operational efficiencies, safety and ergonomics. She also has managed quality control analytical laboratory operations in support of U.S. and international markets.
Linda received a Bachelor of Arts in Chemistry degree and an MBA from Virginia Tech. She is an ASQ Certified Manager of Quality/Organizational Excellence and holds an Aseptic Processing Training Certification from the Aseptic Training Institute. She has been a member in the American Association of Pharmaceutical Scientists and American Chemical Society and enjoys volunteering in her local community.